Rapid Ebola Immunoassay From Corgenix Gains Authorization
This article was originally published in The Gray Sheet
Executive Summary
The firm's ReEBOV assay, which can deliver results within 15-25 minutes, is the first rapid test and immunoassay for the Ebola virus granted an emergency use authorization by FDA.